TAO Synergies Inc.
TAO Synergies Inc. (TAOX): 1 pipeline candidate · ~21 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
20.7 months
D/E 0.21 · 3% dilution
Lead: Phase 1
1 candidate
N/A
N/A
A transparent, data-derived signal for TAO Synergies Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$29.4M
Cash
$3.6M
Quarterly Burn
$1.7M
Runway
20.7 mo
Revenue
$389K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| bryostatin-1 | Phase 1 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
24
Total value held
$2.9M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 158,738 | $903K |
| renaissance technologies llc | 101,800 | $579K |
| geode capital management, llc | 88,644 | $505K |
| vanguard fiduciary trust co | 45,432 | $259K |
| morgan stanley | 24,359 | $139K |
| blackrock, inc. | 19,753 | $112K |
| state street corp | 19,300 | $110K |
| dimensional fund advisors lp | 12,619 | $72K |
| northern trust corp | 12,126 | $69K |
| ubs group ag | 10,750 | $61K |
Showing top 10 of 24 institutional holders of TAO Synergies Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in TAO Synergies Inc.'s pipeline?
TAO Synergies Inc. (TAOX) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is TAO Synergies Inc.'s lead drug candidate?
TAO Synergies Inc.'s most advanced tracked candidate is bryostatin-1 (Phase 1) for Multiple Sclerosis.
What is TAO Synergies Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, TAO Synergies Inc. has approximately 20.7 months of cash runway.
What is TAO Synergies Inc.'s market capitalization?
TAO Synergies Inc.'s market capitalization is approximately $29.4M.
Who is the CEO of TAO Synergies Inc.?
Parkfield Funding is the chief executive officer of TAO Synergies Inc. (TAOX).
Get the full picture on TAO Synergies Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.